(Press-News.org) PLYMOUTH MEETING, PA [April 15, 2024] — The National Comprehensive Cancer Network® (NCCN®) and the NCCN Foundation® today announced five winners for the 2024 NCCN Foundation Young Investigator Awards (YIA). These annual awards honor some of the most promising new oncology researchers from across NCCN’s Member Institutions. Investigator selection and project oversight is organized through the NCCN Oncology Research Program (ORP). Funding of up to $150,000 over two years per awardee will be provided by the NCCN Foundation.
“It is always a great honor to be able to support up-and-coming talent in the field of cancer research,” said Crystal S. Denlinger, MD, Chief Executive Officer, NCCN—a former NCCN Foundation YIA recipient. “We have the honor of supporting people who are involved in exciting new research and give them tools to take their careers—and our understanding of cancer—to an even higher level. I congratulate all five recipients and look forward to seeing what they do in the future.”
The 2024 NCCN Foundation Young Investigator Award recipients are:
Zachary Burke, MD, Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
Identification and Exploitation of Collateral Sensitivity in Treatment Resistant Osteosarcoma
Alexander Muir, PhD, The UChicago Medicine Comprehensive Cancer Center
Targeting Microenvironmental Synthetic Lethalities in Pancreatic Cancer
Andreas Rauschecker, MD, PhD, MSc, UCSF Helen Diller Family Comprehensive Cancer Center
Deep Learning Radiogenomic Analysis of Primary CNS Lymphoma on Brain MRI
James Smithy, MD, MHS, Memorial Sloan Kettering Cancer Center
A Phase 2 Trial of IO102/IO103 and Nivolumab-Relatlimab Fixed-dose Combination in Previously Untreated, Unresectable Melanoma
Jennifer N. Vega, PhD, Vanderbilt-Ingram Cancer Center
Neuroplasticity-Based Cognitive Remediation for Persistent Cancer/ Chemotherapy-Related Cognitive Impairment
“The YIA program is a cornerstone of our work to advance cancer care,” said Patrick Delaney, Executive Director, NCCN Foundation. “These awards help cultivate and encourage some of the nation’s top next-generation cancer researchers as they guide the course of treatment innovation and advancement.”
Results from these studies will be presented at a future NCCN Annual Conference. During the recent NCCN 2024 Annual Conference, past YIA recipients presented research findings that included immune cell dysfunction, the complementary roles of multiple care teams for CAR T-cell therapy, advanced colorectal and esophagogastric cancers, diverse genetics in cervical cancer, oncogenic dependency in kidney cancer, mucosal melanomas, and radium-223 in prostate cancer. Those abstracts can be found published at JNCCN.org, the online home of JNCCN—Journal of the National Comprehensive Cancer Network.
This year’s awards were made possible through support from the NCCN Foundation with additional funding from AbbVie; Daiichi Sankyo; Edith C. Blum Foundation; Joanne Mohr-Hartshorne; Merck & Co., Inc.; and Pfizer Inc. The NCCN Foundation has awarded more than $11.1 million since 2011 through the YIA program, to a total of 75 researchers. Visit NCCN.org/YIA to learn more about the program and past recipients.
# # #
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.
About the NCCN Foundation
The NCCN Foundation empowers people with cancer and their caregivers by delivering unbiased expert guidance from the world’s leading cancer experts through the library of NCCN Guidelines for Patients® and other patient education resources. The NCCN Foundation is also committed to advancing cancer treatment by funding the nation’s promising young investigators at the forefront of cancer research. For more information about the NCCN Foundation, visit nccnfoundation.org.
END
Monday, April 15, 2024 - Toronto - From a young age, people learn the importance of paying attention to the environment around them. Less emphasized is the value of paying attention to their inner environment. Neuroscientists are increasingly studying how looking inward via mindfulness training can affect everything from depression and memory to stress levels and aging. As researchers work to uncover the neural mechanisms underlying these brain changes, they hope to elucidate best practices for people who want to incorporate mindfulness in their lives.
“Attentional training is a mechanism by which you can train your brain,” says Erika Nyhus of Bowdoin College, who is chairing ...
Sport junkie or couch potato? Always on time or often late? The animal kingdom, too, is home to a range of personalities, each with its own lifestyle. In a study just released in the journal PLOS Biology, a team led by Sören Häfker and Kristin Tessmar-Raible from the Alfred Wegener Institute, Helmholtz Centre for Polar and Marine Research (AWI) and the University of Vienna report on a surprising discovery: even simple marine polychaete worms shape their day-to-day lives on the basis of highly individual rhythms. This diversity ...
Bethesda, MD (April 15, 2024) - The American Gastroenterological Association (AGA) and Target RWE have partnered to significantly expand real-world data available for serious, and often chronic, gastroenterological diseases. This partnership will also allow Target RWE to incorporate AGA’s eosinophilic esophagitis (EoE) severity index tool, I-SEE, into the TARGET-GASTRO registry.
AGA led the international team of more than 30 multidisciplinary experts that developed the Index of Severity for EoE (I-SEE) in 2022. I-SEE is the first-ever severity index for eosinophilic esophagitis, which provides a simple system for physicians to assess and track ...
A University of Michigan study has shown that traumatic experiences during childhood may get "under the skin" later in life, impairing the muscle function of people as they age.
The study examined the function of skeletal muscle of older adults paired with surveys of adverse events they had experienced in childhood. It found that people who experienced greater childhood adversity, reporting one or more adverse events, had poorer muscle metabolism later in life. The research, led by University of Michigan Institute for Social Research scientist Kate Duchowny, is published in Science Advances.
Duchowny and her co-authors used ...
MEDIA INQUIRES
WRITTEN BY
Laura Muntean
Ashley Vargo
laura.muntean@ag.tamu.edu
ashley.vargo@ag.tamu.edu
601-248-1891
Depiction ...
Over the past few years, people have generally become more conscious about the food they consume. Thanks to easier access to information as well as public health campaigns and media coverage, people are more aware of how nutrition ties in with both health benefits and chronic diseases. As a result, there is an ongoing cultural shift in most countries, with people prioritizing eating healthily. In turn, the demand for healthier food options and nutritional supplements is steadily growing.
In line with these changes, Assistant Professor Kyohei ...
A new study conducted by researchers at Tampere University and Tampere University Hospital revealed how aberrant epigenetic regulation contributes to the development of atypical teratoid/rhabdoid (AT/RT) tumours, which are aggressive brain tumours that mainly affect young children. There is an urgent need for more research in this area as current treatment options are ineffective against these highly malignant tumours.
Most tumours take a long time to develop as harmful mutations gradually accumulate in cells’ DNA over time. AT/RT tumours are a rare exception, ...
700 million years ago, a remarkable creature emerged for the first time. Though it may not have been much to look at by today’s standards, the animal had a front and a back, a top and a bottom. This was a groundbreaking adaptation at the time, and one which laid down the basic body plan which most complex animals, including humans, would eventually inherit.
The inconspicuous animal resided in the ancient seas of Earth, likely crawling along the seafloor. This was the last common ancestor of bilaterians, ...
Embargo: This journal article is under embargo until April 15 at 10 a.m. BST/London (5 a.m. EDT/3 a.m. MDT). Media may conduct interviews around the findings in advance of that date, but the information may not be published, broadcast, or posted online until after the release window. Journalists are permitted to show papers to independent specialists under embargo conditions, solely for the purpose of commenting on the work described
University researchers have shown that a transition to green wastewater-treatment approaches in the U.S. that leverages the potential of carbon-financing could save a staggering $15.6 billion and just under 30 million tonnes of CO2-equivalent emissions ...
Important differences in how the nasal cells of young and elderly people respond to the SARS-CoV-2 virus, could explain why children typically experience milder COVID-19 symptoms, finds a new study led by researchers at UCL and the Wellcome Sanger Institute.
The study, published in Nature Microbiology, focused on the early effects of SARS-CoV-2 infection on the cells first targeted by the viruses, the human nasal epithelial cells (NECs).
These cells were donated from healthy participants from Great Ormond Street Hospital (GOSH), University College London Hospital (UCLH) and the Royal ...
